1- (4- (2- (6- amino- 8- ((6- bromo- 1,3- benzodioxol- 5- yl)sulfanyl)- 9H- purin- 9- yl)ethyl)piperidin- 1- yl)- 2- hydroxypropan- 1- one

11/02/2023 - "Finally, the investigated molecular mechanism demonstrated that the combination of DOX and MPC-3100 induced apoptosis in breast cancer cells more efficiently than either drug alone. "
11/02/2023 - "Firstly, molecular docking analyses were performed, and then the MTT test was conducted to evaluate the individual and combined cytotoxic effects of DOX and MPC-3100 on MCF-7 and MDA-MB-231 breast cancer cell lines. "
11/02/2023 - "This study showed a possible coordinated mechanism of action between DOX and MPC-3100, pointing to the possibility of a more effective therapeutic strategy for breast cancer therapy."
11/02/2023 - "Enhancing therapeutic efficacy in breast cancer: a study on the combined cytotoxic effects of doxorubicin and MPC-3100."
11/02/2023 - "This study aimed to examine the cytotoxic and apoptotic effects of the traditional chemotherapeutic agent doxorubicin (DOX) and the next-generation HSP90 inhibitor MPC-3100 on breast cancer cell lines. "